Advertisement

Topics

Hatch aims to promote biosimilars and generics and restrict litigation

05:07 EDT 13 Jul 2018 | Generics and Biosimilars Initiative

Senator Orrin Hatch filed an amendment to the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act, which was advanced to the Senate by the Judiciary Committee on 14 June 2018.

Original Article: Hatch aims to promote biosimilars and generics and restrict litigation

NEXT ARTICLE

More From BioPortfolio on "Hatch aims to promote biosimilars and generics and restrict litigation"

Advertisement
Quick Search
Advertisement
Advertisement